Dr. Serge Beaulieu, MD
Claim this profileDouglas Mental Health University Institute
Studies Depression
Studies Bipolar Disorder
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Serge Beaulieu, MD is currently running
Cannabidiol
for Bipolar Depression
This trial is testing CBD, a chemical from the cannabis plant, to see if it can help people with bipolar depression who haven't responded to standard treatments. CBD might work by balancing brain chemicals that influence mood.
Recruiting1 award Phase 3
Brexpiprazole
for Bipolar Disorder
Bipolar disorder (BD) is a frequent and lifelong recurrent mood disorder with treatment-resistant depressive episodes. Importantly, depressive symptoms and cognitive decline are major determinants of functionality and quality of life in this clinical population. There is robust evidence that individuals with BD have neurocognitive deficits (especially in memory and executive functioning domains) compared to the healthy population. These deficits are present in all mood states and can greatly affect patients' functional capacity, often more so than mood symptoms themselves. Many pharmacological treatments for BD adversely affect cognition, and those that are beneficial can be difficult to use. There is thus a pressing need to identify a safe, easy-to-use medication that can target both cognitive deficits and depressive symptoms in BD. It is expected that Brexpiprazole adjunctive treatment will be efficacious in treating BD type I and type II depression by improving mood symptoms, as well as cognitive capacity and global functioning, and that such changes will be accompanied by concurrent alterations in associated brain structures.
Recruiting2 awards Phase 313 criteria
More about Serge Beaulieu, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Serge Beaulieu, MD has experience with
- Brexpiprazole
- Cannabidiol
- Placebo
- Northern Light Technology (SADelite Lamp) Bright Light-therapy
- Northern Light Technology (SADelite Lamp) Dim Light-therapy
Breakdown of trials Serge Beaulieu, MD has run
Depression
Bipolar Disorder
Depression, Bipolar Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Serge Beaulieu, MD specialize in?
Serge Beaulieu, MD focuses on Depression and Bipolar Disorder. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Serge Beaulieu, MD currently recruiting for clinical trials?
Yes, Serge Beaulieu, MD is currently recruiting for 2 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Serge Beaulieu, MD has studied deeply?
Yes, Serge Beaulieu, MD has studied treatments such as Brexpiprazole, Cannabidiol, Placebo.
What is the best way to schedule an appointment with Serge Beaulieu, MD?
Apply for one of the trials that Serge Beaulieu, MD is conducting.
What is the office address of Serge Beaulieu, MD?
The office of Serge Beaulieu, MD is located at: Douglas Mental Health University Institute, Montreal, Quebec H4H 1R3 Canada. This is the address for their practice at the Douglas Mental Health University Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.